Gomekli
Payments companies reported to CMS as associated with Gomekli. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Gomekli, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Gomekli
These are the largest totals companies reported as associated with Gomekli. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Zsila Sadighi | Houston, TX | Neurology (Psychiatry & Neurology) | $69,502.32 |
| Phioanh Nghiemphu | Los Angeles, CA | Neurology (Psychiatry & Neurology) | $55,608.47 |
| Timothy Gershon | Chapel Hill, NC | Pediatrics | $48,186.62 |
| Mina Lobbous | Birmingham, AL | Neurology (Psychiatry & Neurology) | $29,775.38 |
| Lauren Weintraub | Albany, NY | Pediatric Hematology-Oncology | $17,361.67 |
| Fouad Hajjar | Orlando, FL | Pediatric Hematology-Oncology | $11,943.85 |
| Tobias Walbert | Detroit, MI | Neurology (Psychiatry & Neurology) | $11,889.74 |
| Angela Hirbe | Saint Louis, MO | Medical Oncology | $10,326.21 |
| Ehsan Rahimy | Stanford, CA | Retina Specialist | $7,984.60 |
| Alipi Bonm | Seattle, WA | Neurology (Psychiatry & Neurology) | $7,763.81 |
Prescribed Gomekli?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.